PAX8 plays an essential antiapoptotic role in uterine serous papillary cancer-Reference-Cited by-同舟云学术

PAX8 plays an essential antiapoptotic role in uterine serous papillary cancer

Published:2021-07-09 Issue:34 Volume:40 Page:5275-5285
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Fares Basem,Berger Liron,Bangiev-Girsh Einav,Kakun Reli Rachel,Ghannam-Shahbari Dima,Tabach Yuval^ORCID,Zohar Yaniv,Gottlieb Eyal^ORCID,Perets Ruth^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-021-01925-z.pdf

Reference67 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7–30.

2. Winterhoff B, Thomaier L, Mullany S, Powell MA. Molecular characterization of endometrial cancer and therapeutic implications. Curr Opin Obstet Gynecol. 2020;32:76–83.

3. Kurman RJ, Visvanathan K, Shih I-M. Bokhman’s dualistic model of endometrial carcinoma. Revisit Gynecol Oncol. 2013;129:271–2.

4. Fadare O, Zheng W. Endometrial serous carcinoma (uterine papillary serous carcinoma): precancerous lesions and the theoretical promise of a preventive approach. Am J Cancer Re.s 2012;2:335–9.

5. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Onco.l 1983;15:10–7.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-nuclei sequencing of uterine serous carcinoma reveals racial differences in immune signaling;Proceedings of the National Academy of Sciences;2024-08-12

2. An unusual uterine papillary serous carcinoma with post therapy disseminating metastasis presenting as primary renal malignancy: a case report;Annals of Medicine & Surgery;2024-01

3. Prolidase-proline oxidase axis is engaged in apoptosis induction by birch buds flavonol santin in endometrial adenocarcinoma cell line;Frontiers in Molecular Biosciences;2023-09-06

4. Significance analysis of PAX8 expression in endometrial carcinoma;Medicine;2022-10-21

5. PAX8 as a Potential Target for Ovarian Cancer: What We Know so Far;OncoTargets and Therapy;2022-10